Infection, cases due to SARS-CoV-2 in rural areas during early COVID-19 vaccination: findings from serosurvey study in a rural cohort of eastern India. (3rd March 2022)

• Record Type: Journal Article
• Authors: Dash, Pujarini; Mansingh, Asit; Nayak, Soumya Ranjan; Sahoo, Debadutta; Bhattacharya, Debdutta; Kanungo, Srikanta; Kshatri, Jaya Singh; Mishra, Bijaya Kumar; Pattnaik, Matrujyoti; Parai, Debaprasad; Choudhary, Hari Ram; Nayak, Swetalina; Rana, Khokan; Alice, Alice; Sahoo, Ajay Kumar; Mohanty, Kanhu Charan; Mohanty, Prasantajyoti; Doley, Chinki; Jain, Hitesh; Majhi, Dasharatha; Pattanayak, Pooja; Behuria, Santosh; Panda, Soumya; Bhoi, Somnath; Pati, Sanghamitra; Palo, Subrata Kumar
• Is Part Of: Epidemiology and infection. Volume 150(2022)
• Publication Date: 2022-03-03
• Subjects: Coronavirus -- sero-survey -- rural area -- epidemiology; Communicable diseases -- Periodicals; Epidemiology -- Periodicals; 614.4
• DOI: 10.1017/S0950268822000346
• Languages: English
• ISSNs: 0950-2688

Abstract

Abstract: COVID-19 serosurvey provides a better estimation of people who have developed antibody against the infection. But limited information on such serosurveys in rural areas poses many hurdles to understand the epidemiology of the virus and to implement proper control strategies. This study was carried out in the rural catchment area of Model Rural Health Research Unit in Odisha, India during March–April 2021, the initial phase of COVID vaccination. A total of 60 village clusters from four study blocks were identified using probability proportionate to size sampling. From each cluster, 60 households and one eligible participant from each household (60 per cluster) were selected for the collection of blood sample and socio-demographic data. The presence of SARS-CoV-2 antibody was tested using the Elecsys Anti-SARS-CoV-2 immunoassay. The overall seroprevalence after adjusting for test performance was 54.21% with an infection to case ratio of 96.89 along with 4.25% partial and 6.79% full immunisation coverage. Highest seroprevalence was observed in the age group of 19–44 years and females had both higher seroprevalence as well as vaccine coverage. People of other backward caste also had higher seropositivity than other caste categories. The study emphasises on continuing surveillance for COVID-19 cases and prioritizing COVID-19 vaccination for susceptible groups for better disease management.